{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-061978","form_type":"8-K","ticker":"XWEL","cik":"0001410428","company_name":"XWELL, Inc.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.299397+00:00","generated_at":"2026-06-01T22:50:08.793304+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"XWELL Q1 revenue up 24% to $8.7M; operating loss narrows 62% to $2.4M","bullets":["Revenue $8.7M vs $7.1M YoY; XpresSpa/Treat $4.4M, XpresTest $3.6M, Naples Wax $0.6M.","Operating loss improved 62% to $2.4M; net loss $2.5M vs $5.5M.","Cash $4.3M, marketable securities $14.8M; no long-term debt.","CDC TGS program expanded to Miami/Chicago; estimated funding increased to $36.7M.","Plans to open 3 new Naples Wax Centers in 2024 and XpresSpa at NYC Penn Station this summer."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-061978","json":"https://secwatch.observer/filing/0001104659-24-061978.json","markdown":"https://secwatch.observer/filing/0001104659-24-061978.md","text":"https://secwatch.observer/filing/0001104659-24-061978.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410428/000110465924061978/0001104659-24-061978-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410428/000110465924061978/tm2414488d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T22:50:08.793304+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c4725f1bbc4faf4bee1650676c606494ffdc1dd1","claim":"XWELL, Inc. reported financial results for the first quarter ended March 31, 2024.","evidence_excerpt":"On May 15, 2024, XWELL, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2024, and provided a corporate update.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465924061978/0001104659-24-061978-index.htm","confidence":0.88,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}